Ultherapy was tested for about one year before FDA approval. When all patients (many over age 65) were included in the studies, 80% responded to treatment and half of the non-responders had a response with a second treatment. You can read more about the FDA study on the Ultherpay manufacturer’s website. Though we can not guarantee results, we will treat patients a second time at no cost. Learn more on our blog about Ultherapy outcomes after the age of 65.